Shine-On BioMedical Co.,Ltd.
Shine-On BioMedical Co.,Ltd. research, develops, and manufactures anti-cancer related drug products. It also develops antibody anticancer drugs, such as exosome anti-cancer drugs, that includes SOB101 and SOB102; SOB201 for engineered multi-target exosomes; SOA101, a dual immune checkpoint T cell adapter antibody; and SOA201, a trispecific adapter immune cell antibody. Shine-On BioMedical Co.,Ltd… Read more
Shine-On BioMedical Co.,Ltd. (6926) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.086x
Based on the latest financial reports, Shine-On BioMedical Co.,Ltd. (6926) has a cash flow conversion efficiency ratio of -0.086x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-83.99 Million) by net assets (NT$972.93 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Shine-On BioMedical Co.,Ltd. - Cash Flow Conversion Efficiency Trend (2021–2024)
This chart illustrates how Shine-On BioMedical Co.,Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Shine-On BioMedical Co.,Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shine-On BioMedical Co.,Ltd. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
IMMUCELL CORP. DL-10
F:IUL
|
N/A |
|
Coreline Soft, Co., Ltd.
KQ:384470
|
-1.079x |
|
Scottie Resources Corp
OTCQB:SCTSF
|
-1.010x |
|
Swelect Energy Systems Limited
NSE:SWELECTES
|
0.071x |
|
Hsin Ba Ba Corp
TW:9906
|
-0.129x |
|
Gala Precision Engineering
NSE:GALAPREC
|
N/A |
|
Boab Metals Limited
PINK:PMYLF
|
-0.108x |
|
Waga Energy SA
PA:WAGA
|
-0.042x |
Annual Cash Flow Conversion Efficiency for Shine-On BioMedical Co.,Ltd. (2021–2024)
The table below shows the annual cash flow conversion efficiency of Shine-On BioMedical Co.,Ltd. from 2021 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$1.02 Billion | NT$-91.45 Million | -0.090x | -279.97% |
| 2023-12-31 | NT$1.14 Billion | NT$-26.88 Million | -0.024x | -28.16% |
| 2022-12-31 | NT$1.17 Billion | NT$-21.66 Million | -0.018x | -164.10% |
| 2021-12-31 | NT$907.57 Million | NT$-6.34 Million | -0.007x | -- |